Pharmacological research
Cure8 research brief
Why This Matters
The review links ER stress and mitochondrial dysfunction to core IBD processes (inflammation, barrier damage, cell death) and highlights MERCs as an integrated signaling hub, suggesting new biomarker and therapeutic directions relevant to IBD research and future care.
Who Should Pay Attention
Researchers, translational scientists, and clinicians focused on IBD pathogenesis, biomarkers, and novel therapeutic targets.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a narrative review (abstract-level summary provided) that synthesizes molecular mechanisms linking ER stress, mitochondrial damage, calcium signaling, oxidative stress, autophagy, and the unfolded protein response in IBD.
The authors emphasize that ER–mitochondria contact sites coordinate these signals and may be a focal point for new diagnostics or treatments. The review discusses potential diagnostic biomarkers and therapeutic approaches arising from these pathways but does not present new clinical trial results.
The structured content is based on the article abstract provided by PubMed, not on independent verification of primary data.
Keep In Mind
This is an abstract-level review article; it summarizes existing molecular and preclinical work rather than reporting new clinical trial results. Any diagnostic or therapeutic suggestions in the review will need validation in clinical studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationPharmacological research
AuthorsShuangshuang Li, Tongyou Zou, Jiaxuan Tian +6 more
InstitutionHunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan Province, China; Institute of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan Province, China; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan Province, China.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedOct 14, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Houpan Song reports financial support was provided by National Natural Science Foundation of China. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Declaration of competing interest The authors declare that they have no conflict of interest.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
FUT2-mediated α1,2-fucosylation in inflammatory bowel disease: mechanisms and translational potential.
FUT2 connects genetics, mucosal sugars, and the gut microbiome — pathways that could help explain why some people with IBD have different microbiomes or disease risk. If validated in trials, FUT2-targeted or...
Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.
Oxidative stress may be a key driver of inflammation in IBD and could point to new biomarkers or adjunctive treatments (dietary changes, antioxidant strategies, or targeted pathways like Nrf2 and ferroptosis) that...
Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.
Protease and serpin activity affect the gut barrier, immunity, and microbial ecology—processes central to IBD. Integrating these pathways could help identify biomarkers or targets that explain why IBD varies between...